Despite the remarkable progress in wastewater treatment strategies over the past decades, the degradation of micro-pollutants still remains a challenging domain to explore, and often, the treated effluent is disposed of without taking care of the same.In this study, a conical plug-and-play reactor (CPPR) was designed to be retrofitted into the existing tertiary treatment point for treating real-life pharmaceutical effluents.Two pharmaceutical effluents (sample I/II) from different treatment plants were treated in CPPR by optimizing the operational parameters and conjugating with other oxidizing agents.The standalone CPPR resulted in the highest COD reduction of 34% and 37% for samples I and II at the optimized values of 2400 rpm, 150 passes, and pH 2.0.The CPPR conjugated with advanced oxidation processes showed an optimal COD reduction of 84%, 81%, and 90% for sample I and 87%, 84%, and 92% for sample II at 0.3 g/L of H2O2, 1:3 Fe2+:H2O2 ratio, and 3 g/h of O3 loading, resp.From an energetic and economic point of view, the performance of HC+O3 surpassed that of other oxidizing agents.Further, the techno-economic feasibility was demonstrated with a break-even anal. for financial estimations of potential pilot-scale incorporation of this technol.